0.615
0.16%
0.001
Schlusskurs vom Vortag:
$0.614
Offen:
$0.627501
24-Stunden-Volumen:
47,428
Relative Volume:
0.60
Marktkapitalisierung:
$18.38M
Einnahmen:
$38.25M
Nettoeinkommen (Verlust:
$-17.87M
KGV:
-8.7857
EPS:
-0.07
Netto-Cashflow:
$4.33M
1W Leistung:
+4.90%
1M Leistung:
-16.16%
6M Leistung:
-34.62%
1J Leistung:
-46.05%
Retractable Technologies Inc Stock (RVP) Company Profile
Firmenname
Retractable Technologies Inc
Sektor
Telefon
972-294-1010
Adresse
511 Lobo Lane, Little Elm, TX
Vergleichen Sie RVP mit anderen Aktien
Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
---|---|---|---|---|---|---|
RVP
Retractable Technologies Inc
|
0.615 | 18.38M | 38.25M | -17.87M | 4.33M | -0.07 |
ISRG
Intuitive Surgical Inc
|
538.55 | 192.83B | 7.87B | 2.24B | 586.00M | 4.25 |
BDX
Becton Dickinson Co
|
221.98 | 64.77B | 20.18B | 1.73B | 3.07B | 5.51 |
ALC
Alcon Inc
|
88.23 | 43.75B | 9.76B | 1.16B | 665.00M | 0.72 |
RMD
Resmed Inc
|
249.33 | 36.84B | 4.81B | 1.11B | 1.35B | 6.16 |
WST
West Pharmaceutical Services Inc
|
323.32 | 23.33B | 2.88B | 499.60M | 321.60M | 7.41 |
Retractable Technologies Inc Aktie (RVP) Neueste Nachrichten
Safety Syringes Market: Safeguarding Healthcare with Advanced Needle Safety Solutions - openPR
Retractable Technologies, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
Retractable Technologies reports loss of USD 5.1M in Q3 2024 - Medical Buyer
Retractable Technologies: Q3 Earnings Snapshot - New Haven Register
Retractable Technologies Inc (RVP) Quarterly 10-Q Report - Quartzy
Retractable Technologies, Inc. Results for the Periods Ended September 30, 2024 - The Bakersfield Californian
Retractable Technologies Reports Steep Q3 Loss as Margins Collapse, Tariffs Bite | RVP Stock News - StockTitan
Retractable Technologies CEO Thomas Shaw acquires $5,422 in stock - Investing.com
Retractable Technologies CEO Thomas Shaw acquires $8,150 in stock By Investing.com - Investing.com Australia
RVP stock touches 52-week low at $0.7 amid market challenges - Investing.com Australia
Retractable Technologies CEO Thomas Shaw acquires $8,150 in stock - Investing.com India
Disposable Syringes Market Overall Study Report 2024-2031 | B. - openPR
Feds Can Hold Proceeds During Chinese Syringe Duties Fight - Law360
Retractable Technologies CEO Thomas J. Shaw acquires $6,876 in stock - Investing.com
Retractable Technologies (NYSE:RVP) Earns Hold Rating from Analysts at StockNews.com - Defense World
Head-To-Head Comparison: Neuronetics (NASDAQ:STIM) and Retractable Technologies (NYSE:RVP) - Defense World
Retractable Technologies CEO Thomas Shaw acquires $6,128 in stock - Investing.com
Retractable Technologies CEO Thomas Shaw acquires $6,128 in stock By Investing.com - Investing.com UK
Retractable Technologies stock hits 52-week low at $0.71 By Investing.com - Investing.com Australia
Retractable Technologies CEO Thomas Shaw buys shares for $429 - Investing.com
Retractable Technologies CEO Thomas Shaw buys shares for $429 By Investing.com - Investing.com Australia
Retractable Technologies stock hits 52-week low at $0.71 - Investing.com India
Retractable Technologies CEO Thomas Shaw buys $8,180 in stock By Investing.com - Investing.com Canada
Retractable Technologies CEO Thomas Shaw buys $8,180 in stock - Investing.com
Retractable Technologies CEO Thomas Shaw acquires $15,661 in stock - Investing.com
Retractable Technologies CEO Thomas Shaw acquires $15,661 in stock By Investing.com - Investing.com Australia
Retractable Technologies CEO Shaw buys $6,061 in stock By Investing.com - Investing.com South Africa
Retractable Technologies CEO Shaw buys $6,061 in stock - Investing.com
Safety Syringes Market 2024-2031 Global Industry Analysis, - openPR
Smart Syringes Market Projected to Surge to USD 143.93 Million by 2031 - WhaTech
Retractable Technologies CEO Thomas J. Shaw acquires $4,632 in stock - Investing.com India
Retractable Technologies CEO Thomas J. Shaw acquires $4,632 in stock By Investing.com - Investing.com South Africa
Hypodermic Needles Market Generated Opportunities, Future - openPR
Venous Blood Collection Market to Witness Huge Growth by 2032 |Terumo, BD, Bio Rad Laboratories, Nipro - openPR
Retractable sues Becton alleging patent infringement - Reuters
Disposable Syringes Market Forecasting Dynamic Growth: - openPR
Smart Syringes Industry: Insights from Latest Research Report on Business Opportunities by (2024-2034) - IndiaPolitics.com
U.S. Disposable Syringes Market Analysis 2024-2030: Rising Vaccine Demand and Growing Adoption of - Daily Guardian Canada
U.S. Disposable Syringes Market Analysis 2024-2030: Rising - GlobeNewswire
Finanzdaten der Retractable Technologies Inc-Aktie (RVP)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):